Tyrosine phosphatase Shp2 and acute lung injury
10.12092/j.issn.1009-2501.2025.10.016
- VernacularTitle:酪氨酸磷酸酶Shp2与急性肺损伤
- Author:
Haoyu JI
1
;
Lilong QIN
1
;
Lei ZHA
1
;
Hanli WANG
1
;
Yusheng CHENG
1
Author Information
1. 皖南医学院第一附属医院呼吸与危重症医学科,芜湖 241000,安徽
- Publication Type:Journal Article
- Keywords:
phosphatase;
lung injury;
pulmonary infection
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2025;30(10):1436-1440
- CountryChina
- Language:Chinese
-
Abstract:
Acute lung injury(ALI)is a common critical illness caused by intrapulmonary or extra-pulmonary factors,which is accompanied by ex-tremely high morbidity and mortality.Its pathogen-esis is extremely complex and difficult to treat.Src homology 2 domain-containing protein tyrosine phosphatase(Shp2),a key cellular signal transduc-tion molecule,plays a pivotal role in the pathophys-iological processes of diverse diseases.Notably,in the context of pathogen infection,Shp2 regulates the functionality of cellular immunity,lung epitheli-al cells,and vascular endothelial cells.This review article highlights the significant role of Shp2 in the onset and progression of ALI,emphasizing its regu-lation of inflammatory response,apoptosis,and ox-idative stress.Shp2 could emerge as a novel thera-peutic target for ALI,offering valuable insights for the development of innovative drug candidates to treat this debilitating condition.